Central voice production and pathophysiology of spasmodic dysphonia

被引:23
作者
Mor, Niv [1 ]
Simonyan, Kristina [2 ,3 ]
Blitzer, Andrew [2 ,4 ]
机构
[1] Maimonides Hosp, Voice & Swallowing Disorders, Div Otolaryngol Head & Neck Surg, 919 49th St, Brooklyn, NY 11219 USA
[2] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA
[4] New York Ctr Voice & Swallowing Disorders, New York, NY USA
关键词
Laryngeal motor cortex; phonation; voice; spasmodic dysphonia; laryngeal dystonia; botulinum toxin; ADDUCTOR DENERVATION-REINNERVATION; THYROARYTENOID MUSCLE RESPONSES; LARYNGEAL MYOTATIC REFLEXES; AIR-PRESSURE STIMULATION; NERVOUS-SYSTEM CONTROL; TERM-FOLLOW-UP; SPASTIC DYSPHONIA; BOTULINUM TOXIN; MOTOR CORTEX; DYSTONIA;
D O I
10.1002/lary.26655
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ObjectiveOur ability to speak is complex, and the role of the central nervous system in controlling speech production is often overlooked in the field of otolaryngology. In this brief review, we present an integrated overview of speech production with a focus on the role of central nervous system. The role of central control of voice production is then further discussed in relation to the potential pathophysiology of spasmodic dysphonia (SD). Data SourcesPeer-review articles on central laryngeal control and SD were identified from PUBMED search. Selected articles were augmented with designated relevant publications. Review MethodsPublications that discussed central and peripheral nervous system control of voice production and the central pathophysiology of laryngeal dystonia were chosen. ResultsOur ability to speak is regulated by specialized complex mechanisms coordinated by high-level cortical signaling, brainstem reflexes, peripheral nerves, muscles, and mucosal actions. Recent studies suggest that SD results from a primary central disturbance associated with dysfunction at our highest levels of central voice control. The efficacy of botulinum toxin in treating SD may not be limited solely to its local effect on laryngeal muscles and also may modulate the disorder at the level of the central nervous system. ConclusionFuture therapeutic options that target the central nervous system may help modulate the underlying disorder in SD and allow clinicians to better understand the principal pathophysiology. Level of EvidenceNA.Laryngoscope, 128:177-183, 2018
引用
收藏
页码:177 / 183
页数:7
相关论文
共 50 条
  • [21] Treatment of Spasmodic Dysphonia With a Neuromodulating Electrical Implant
    Pitman, Michael J.
    LARYNGOSCOPE, 2014, 124 (11) : 2537 - 2543
  • [22] Spasmodic dysphonia: Acoustic measures
    Sigal, Liliana
    REVISTA DE INVESTIGACION EN LOGOPEDIA, 2013, 3 (01): : 34 - 52
  • [23] Workplace Productivity and Voice Disorders: A Cognitive Interviewing Study on Presenteeism in Individuals With Spasmodic Dysphonia
    Isetti, Derek
    Meyer, Tanya
    JOURNAL OF VOICE, 2014, 28 (06)
  • [24] Psychological factors in spasmodic dysphonia
    KieseHimmel, C
    Zwirner, P
    LARYNGO-RHINO-OTOLOGIE, 1996, 75 (07) : 397 - 402
  • [25] Botulinum Toxin Treatment of Adductor Spasmodic Dysphonia: Longitudinal Functional Outcomes
    Novakovic, Daniel
    Waters, Heather H.
    D'Elia, Joanna B.
    Blitzer, Andrew
    LARYNGOSCOPE, 2011, 121 (03) : 606 - 612
  • [26] PERCEPTUAL-ACOUSTIC RELATIONSHIPS IN SPASMODIC DYSPHONIA
    ZWIRNER, P
    MURRY, T
    WOODSON, GE
    JOURNAL OF VOICE, 1993, 7 (02) : 165 - 171
  • [27] Differentiating Between Adductor and Abductor Spasmodic Dysphonia Using Airflow Interruption
    Hoffman, Matthew R.
    Jiang, Jack J.
    Rieves, Adam L.
    McElveen, Kelsey A. B.
    Ford, Charles N.
    LARYNGOSCOPE, 2009, 119 (09) : 1851 - 1855
  • [28] Considerations for Initial Dosing of Botulinum Toxin in Treatment of Adductor Spasmodic Dysphonia
    Rosow, David E. E.
    Parikh, Punam
    Vivero, Richard J. J.
    Casiano, Roy R. R.
    Lundy, Donna S. S.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2013, 148 (06) : 1003 - 1006
  • [29] The Impact of Socioeconomic Status on Voice Outcomes in Patients With Spasmodic Dysphonia Treated With Botulinum Toxin Injections
    Valenzuela, Dianne
    Singer, Joel
    Lee, Terry
    Hu, Amanda
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2019, 128 (04) : 316 - 322
  • [30] The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan
    Hyodo, Masamitsu
    Hisa, Yasuo
    Nishizawa, Noriko
    Omori, Koichi
    Shiromoto, Osamu
    Yumoto, Eiji
    Sanuki, Tetsuji
    Nagao, Asuka
    Hirose, Kahori
    Kobayashi, Taisuke
    Asano, Kento
    Sakaguchi, Masahiko
    AURIS NASUS LARYNX, 2021, 48 (02) : 179 - 184